Article Listing - Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

EUROPEAN ASTHMA TREATMENT MARKET

6 April 1992

Sales of beta-2 agonists in Europe will grow from $485 million in 1990 to almost $983 million by 1995, or...

ROMANIAN HEALTH SECTOR PLANS

6 April 1992

Romania's Minister of Health, Mircea Aiorescu, has announced in Bucharest that his Ministry is planning to change various aspects of...

TAMOXIFEN OF BENEFIT IN OSTEOPOROSIS?

6 April 1992

A US study looking at the effects of Imperial Chemical Industries' synthetic anti-estrogen Nolvadex (tamoxifen) in post-menopausal women with early-stage...

GERMAN PRICE SUPPORT EXTENDED

6 April 1992

The leading German health insurance funds have announced further fixed-price support arrangements for a new range of drug products, and...

GENZYME AND CYSTIC FIBROSIS

6 April 1992

Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms...

ENZON AND CYTOCLONAL PHARMACEUTICS

6 April 1992

Enzon Inc has entered into an agreement with Cytoclonal Pharmaceutics to apply the former's drug delivery technologies to Cytoclonal products...

AUSTRALIAN VACCINE RESEARCH

6 April 1992

The Walter and Eliza Hall Institute of Medical research in Melbourne, Australia, is to set up a commercial joint venture...

GERMAN PRICE SUPPORT EXTENDED

6 April 1992

The leading German health insurance funds have announced further fixed-price support arrangements for a new range of drug products, and...

ASPIRIN HELPS BAYER IN ITALY

6 April 1992

Favorable trends in drugs business and especially good sales of standard products such as aspirin are reported to have helped...

ROBERTS PHARMA ACQUIRES NCRC

6 April 1992

The US concern Roberts Pharma-ceutical has reached a definitive agreement to acquire the National Clinical Research Centers in the USA...

Showing 94381-94390 of 95316 articles